Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12


The PHLPP2 phosphatase is a druggable driver of prostate cancer progression.

Nowak DG, Katsenelson KC, Watrud KE, Chen M, Mathew G, D'Andrea VD, Lee MF, Swamynathan MM, Casanova-Salas I, Jibilian MC, Buckholtz CL, Ambrico AJ, Pan CH, Wilkinson JE, Newton AC, Trotman LC.

J Cell Biol. 2019 May 15. pii: jcb.201902048. doi: 10.1083/jcb.201902048. [Epub ahead of print]


Insulin-like growth factor 1 receptor affects the survival of primary prostate cancer patients depending on TMPRSS2-ERG status.

Mancarella C, Casanova-Salas I, Calatrava A, García-Flores M, Garofalo C, Grilli A, Rubio-Briones J, Scotlandi K, López-Guerrero JA.

BMC Cancer. 2017 May 25;17(1):367. doi: 10.1186/s12885-017-3356-8.


Optimizing the clinical utility of PCA3 to diagnose prostate cancer in initial prostate biopsy.

Rubio-Briones J, Borque A, Esteban LM, Casanova J, Fernandez-Serra A, Rubio L, Casanova-Salas I, Sanz G, Domínguez-Escrig J, Collado A, Gómez-Ferrer A, Iborra I, Ramírez-Backhaus M, Martínez F, Calatrava A, Lopez-Guerrero JA.

BMC Cancer. 2015 Sep 11;15:633. doi: 10.1186/s12885-015-1623-0.


MiR-187 Targets the Androgen-Regulated Gene ALDH1A3 in Prostate Cancer.

Casanova-Salas I, Masiá E, Armiñán A, Calatrava A, Mancarella C, Rubio-Briones J, Scotlandi K, Vicent MJ, López-Guerrero JA.

PLoS One. 2015 May 13;10(5):e0125576. doi: 10.1371/journal.pone.0125576. eCollection 2015.


[Update on the diagnosis of PCa in urine. The current role of urine markers].

Fernandez-Serra A, Casanova-Salas I, Rubio L, Calatrava A, García-Flores M, García-Casado Z, López-Guerrero JA, Rubio-Briones J.

Arch Esp Urol. 2015 Apr;68(3):240-9. Review. Spanish.


External validation of FXYD3 and KRT20 as predictive biomarkers for the presence of micrometastasis in muscle invasive bladder cancer lymph nodes.

Ramírez-Backhaus M, Fernández-Serra A, Rubio-Briones J, Cruz Garcia P, Calatrava A, Garcia Casado Z, Casanova Salas I, Rubio L, Solsona E, López-Guerrero JA.

Actas Urol Esp. 2015 Oct;39(8):473-81. doi: 10.1016/j.acuro.2015.02.002. Epub 2015 Apr 25. English, Spanish.


ERG deregulation induces IGF-1R expression in prostate cancer cells and affects sensitivity to anti-IGF-1R agents.

Mancarella C, Casanova-Salas I, Calatrava A, Ventura S, Garofalo C, Rubio-Briones J, Magistroni V, Manara MC, López-Guerrero JA, Scotlandi K.

Oncotarget. 2015 Jun 30;6(18):16611-22.


Clinico-pathological significance of the molecular alterations of the SPOP gene in prostate cancer.

García-Flores M, Casanova-Salas I, Rubio-Briones J, Calatrava A, Domínguez-Escrig J, Rubio L, Ramírez-Backhaus M, Fernández-Serra A, García-Casado Z, López-Guerrero JA.

Eur J Cancer. 2014 Nov;50(17):2994-3002. doi: 10.1016/j.ejca.2014.08.009. Epub 2014 Sep 6.


[New biomarkers to optimize the selection and follow up of patients with prostate cancer on active surveillance].

López-Guerrero JA, Casanova-Salas I, Fernández-Serra A, Rubio L, Calatrava A, García-Flores M, García-Casado Z, Rubio-Briones J.

Arch Esp Urol. 2014 Jun;67(5):462-72. Review. Spanish.


Identification of miR-187 and miR-182 as biomarkers of early diagnosis and prognosis in patients with prostate cancer treated with radical prostatectomy.

Casanova-Salas I, Rubio-Briones J, Calatrava A, Mancarella C, Masiá E, Casanova J, Fernández-Serra A, Rubio L, Ramírez-Backhaus M, Armiñán A, Domínguez-Escrig J, Martínez F, García-Casado Z, Scotlandi K, Vicent MJ, López-Guerrero JA.

J Urol. 2014 Jul;192(1):252-9. doi: 10.1016/j.juro.2014.01.107. Epub 2014 Feb 8.


Optimizing prostate cancer screening; prospective randomized controlled study of the role of PSA and PCA3 testing in a sequential manner in an opportunistic screening program.

Rubio-Briones J, Casanova J, Dumont R, Rubio L, Fernandez-Serra A, Casanova-Salas I, Domínguez-Escrig J, Ramírez-Backhaus M, Collado A, Gómez-Ferrer A, Iborra I, Monrós JL, Ricós JV, Solsona E, Salas D, Martínez F, Lopez-Guerrero JA.

Actas Urol Esp. 2014 May;38(4):217-23. doi: 10.1016/j.acuro.2013.09.007. Epub 2013 Oct 27. English, Spanish.


miRNAs as biomarkers in prostate cancer.

Casanova-Salas I, Rubio-Briones J, Fernández-Serra A, López-Guerrero JA.

Clin Transl Oncol. 2012 Nov;14(11):803-11. doi: 10.1007/s12094-012-0877-0. Epub 2012 Jul 24. Review.


Supplemental Content

Loading ...
Support Center